Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous and Intravenous Anakinra in COVID-19 Infection (Feasibility & PK/PD)
2020-001636-95Phase 2Unknown
- Sponsor
- The University of Manchester
- Start
- May 2020
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of anakinra in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by The University of Manchester. Primary endpoint: Plasma IL-1Ra levels. Status: unknown.
02
Drugs
anakinra
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001636-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001636-95.